Publications by authors named "Sujeet Pawar"

Article Synopsis
  • Increasing resistance to current antiviral drugs for influenza highlights the need for new treatments, focusing on both drug development and administration methods.
  • CD-6'SLN, a novel entry inhibitor that mimics sialic acid, was formulated into a dry powder using spray drying with a dispersion enhancer, ensuring stability and efficacy in a dry powder inhaler.
  • In tests on infected mice, the aerosolized CD-6'SLN significantly reduced disease severity and inflammation compared to control groups, demonstrating its potential as a new treatment for influenza.
View Article and Find Full Text PDF
Article Synopsis
  • Viruses typically invade cells by attaching to specific molecules on the cell surface, prompting the development of broad-spectrum multivalent entry inhibitors (MEIs) that can mimic these binding sites.
  • To enhance the effectiveness of MEIs, modifications with hydrophobic arms create irreversible inhibition, which maintains efficacy even when diluted, though initial MEIs showed limited reversible inhibition against SARS-CoV-2.
  • Through systematic testing, researchers identified effective small molecules that achieve irreversible inhibition against various viruses, demonstrating success in preventing SARS-CoV-2 infection in a hamster model using both intranasal and aerosol methods.
View Article and Find Full Text PDF

Peripheral nerve damage results in the loss of sensorimotor and autonomic functions, which is a significant burden to patients. Furthermore, nerve injuries greater than the limiting gap length require surgical repair. Although autografts are the preferred clinical choice, their usage is impeded by their limited availability, dimensional mismatch, and the sacrifice of another functional donor nerve.

View Article and Find Full Text PDF

Massive pulmonary embolism (PE) is an uncommon but severe complication of pregnancy or during the first few weeks after giving birth. Our intention was to thoroughly analyze the information available to its management methods. Significant bleeding of mother survival and early deliveries in fetal survivals were having hemorrhage and were having key outcomes.

View Article and Find Full Text PDF
Article Synopsis
  • * A new technique called LODES/MS (logically derived sequence tandem mass spectrometry) has been developed to better identify the structures of these N-glycan isomers.
  • * LODES/MS offers advantages like avoiding the need for chemical modifications and being applicable to various types of N-glycans, validated through experiments with samples from soybean, ovalbumin, and IgY.
View Article and Find Full Text PDF

causes pneumonia and liver abscesses in humans worldwide and contains virulence factor capsular polysaccharides and lipopolysaccharides linked to the cell wall. Although capsular polysaccharides are good antigens for vaccine production and capsular oligosaccharides conjugate vaccines are proven effective against infections caused by encapsulated pathogens, there is still no vaccine available. One obstacle is that the capsular polysaccharide of a dominated serotype K2 is difficult to synthesize chemically due to the three 1,2- linkages in its structure.

View Article and Find Full Text PDF

-glycans on the cell surface provide distinct signatures that are recognized by different glycan-binding proteins (GBPs) and pathogens. Most glycans in humans are asymmetric and isomeric, yet their biological functions are not well understood due to their lack of availability for studies. In this work, we have developed an improved strategy for asymmetric -glycan assembly and diversification using designed common core substrates prepared chemically for selective enzymatic fucosylation and sialylation.

View Article and Find Full Text PDF

A new class of broadly neutralizing antibodies (bNAbs) from HIV donors has been reported to target the glycans on gp120--a glycoprotein found on the surface of the virus envelope--thus renewing hope of developing carbohydrate-based HIV vaccines. However, the version of gp120 used in previous studies was not from human T cells and so the glycosylation pattern could be somewhat different to that found in the native system. Moreover, some antibodies recognized two different glycans simultaneously and this cannot be detected with the commonly used glycan microarrays on glass slides.

View Article and Find Full Text PDF